MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

25 Medtech Startups You Need to Know

Here are 25 startups from the MedTech Innovator Awards Competition that are sure to have a huge impact on the healthcare industry.

  • There are about 25 early-stage companies that could possibly change healthcare and cause us to rethink the we go about treating illnesses. These 25 companies are derived from the MedTech Innovator Competition and the winners of the competition were announced at The MedTech Conference, powered by AdvaMed, in Philadelphia, last month.  Sana Health won first place in the competition and was awarded the $350,000 grand prize to advance its business goals and mission to improve future health outcomes. AblaCare was the second-place winner. CroiValve, FineHeart, and Spect were runners-up. Each company received a prize of $25,000 as finalists in the MedTech Innovator Accelerator program. 

  • AblaCare

    AblaCare is developing a minimally invasive approach for the treatment of polycystic ovary syndrome (PCOS) related infertility.  The company’s approach is focused on duplicating the well-recognized benefits of current surgical ovarian drilling offerings while providing a less risky, less invasive, and less costly procedure than current solutions for PCOS. The Paris-based company is currently finalizing and validating the design of its prototypes in order to get ready for pre-clinical and clinical trials.

    Courtesy of Ablacare
  • AtaCor

    AtaCor is developing the world's first pacing system that keeps the heart and veins free from pacing leads and hardware.  AtaCor said its  substernal pacing lead is inserted without any need for medical imaging, allowing for faster, less-invasive therapy delivery. The unique placement avoids the need to access the patient’s vascular system and leaves the heart completely untouched. Furthermore, the substernal lead is designed to eliminate bedrest restrictions associated with temporary pacing, thereby improving patient mobility and post-procedural recovery.  In September, the  San Clemente, CA-based company  raised $8.8 million in a series A round. 

  • AuriGen

    AuriGen is a structural his a structural heart and EP company, developing an entirely trans-septal implant to treat both the stroke and arrhythmia risk associated with persistent atrial fibrillation. In June, the Galway, Ireland based company raised about €2.5 million in its latest round. 

  • AxioSonic

    AxioSonic is developing a technology that will utilize therapeutic ultrasound for treatment in facial pain in patients diagnosed with chronic rhinosinusitis.

  • BeamLine Diagnostics

    BeamLine Diagnostics is developing a biopsy triaging system that can identify healthy and benign tissue specimens with high accuracy within seconds. Using this system, healthy biopsies could be quickly identified, before undergoing any processing, and eliminated from the histopathology pathway, a protocol called 'resect and discard.'

    Courtesy of BeamLine Diagnostics
  • CoLabs

    CoLabs is developing a smart airway and ventilation system designed to be used during cardiac arrest.

    Courtesy of CoLabs
  • CroiValve

    CroíValve is another company to watch in the cardiovascular space. The Dublin-based firm said it was developing  a safe, effective, and easy way to significantly reduce tricuspid regurgitation in high risk patients.

  • Deneb Medical

    Look out Intuitive Surgical! There's another surgical robotics competitor looking to enter the market.  This time out, San Sebastián, Spain-based Deneb Medical is developing a surgical robot for selective tissue ablation that avoids unintended damage to critical anatomical structures.

    Courtesy of Deneb Medical
  • Deton

    This Pasadena, CA-based company hopes to transform the way we thing about lung disease. To do this,  Deton is providing complete and timely lung health information through an Aerosol Biopsy.


  • Embrace Orthopaedics

    Embrace Orthopaedics could just redefine how we think about joint support. The Vancouver-based company has developed a joint support system that is directly integrated into athletic wear.

    Courtesy of Embrace Orthopaedics
  • Fine Heart

    Fine Heart has developed the  ICOMS technology, which  works either in a systole-synchronized or a continuous mode. In synchronous mode, the device works as an adjunct to the natural heart function and augments cardiac output to optimized levels. For patients with significant ventricular arrhythmias, the device can work in continuous mode to fully carry output requirements. Synchronous (pulsatile) mode is considered to be the primary mode of operation.

  • Ictero Medical

    Ictero Medical has developed what it said is the first definitive and truly minimally-invasive solution to treat gallstone disease. The technology provides the benefit of surgical removal of the gallbladder, without the risk.

  • Medable

    From app to analytics, Medable said it enables healthcare research for wearable and regulated medical devices on mobile, web, and in the cloud. The Palo Alto, CA-based company said it provides the full-stack cloud solution with rich mobile and web apps and real-time device data display and automated alerts.


    MYOVUE said its MY01 capitalizes on clinically proven sensitivity and specificity for diagnosing Acute Compartment Syndrome (ACS). The Montreal-based company said its real-time, accurate muscle pressure measurement allows users to take timely action.

  • NitiNotes

    NitiNotes  said it has developed the endozip, a device it said is a safe, effective,  and long-lasting minimally invasive  solution for treating obesity.

  • Paragate Medical 

    Paragate Medical develops a fully implantable medical device to actively prevent fluid overload in heart failure patients and break the hospitalization cycle. Instead of receiving acute, aggressive and costly diuresis treatments that don’t prevent recurrence congestion, an implantable device can offer a 24/7, non-aggressive, out-of-hospital solution to keep patients balanced at home.

    Courtesy of Paragate Medical
  • PercuSense

    PercuSense is focused on minimally invasive medical devices that use physiological triggers to continuously monitor and proactively diagnose progression of diseases such as sepsis, cancer or diabetes, ultimately enabling more effective, smart therapy. The Valencia, CA-based company's technologies are based on a first-in-category, calibration-free electrochemical sensor that combines principles of glucose detection inspired by islet cell technology with a novel sensing electrode design that yields a low-profile implant and superior mechanical stability.

  • PhotoniCare

    PhotoniCare said it has developed an easy-to-use device is designed to look and handle like the familiar otoscope. OCT images of the middle ear eliminate subjectivity and guesswork for the first time. A nurse-practitioner, physician’s assistant, or technician could perform the exam. The Champaign, IL-based company said this will free up the ENT specialist’s and make lower-cost, objective early screening possible.

  • Pneumonics

    Pneumonics said its PneuMotion provides continuous respiratory rate monitoring and obstructive apnea detection. The Durham, NC-based company said PneuMotion seamlessly integrates into a hospital's existing network and allows mobile respiratory monitoring and EHR data collection. Ultra-low cost sensor technology makes this a cost-effective solution for opioid safety.

  • Sana Health

    Sana Health has developed the smart pain relief mask, developed to help individuals with the worst cases of chronic nerve pain get the relief they long for. The firm's product is a neuromodulation device that integrates a heart rate variability sensor for personalized chronic pain management. The San Francisco - based company said it is focusing on the most severe cases of chronic pain, in order to help those in greatest need first. 

    Courtesy of Sana Health
  • Spect Medical

    Spect Medical is a specialist in giving a diagnosis of the retina. 

    Spect Medical
  • Strados Labs

    Strados Labs helps clinical teams monitor real-time changes in lung health throughout the entire episode of care so they can work to reduce exacerbation risk and create a more activated patient experience.

    Courtesy Strados Labs
  • Tasso

    Tasso said it is working to develop a  simple, intuitive, and virtually painless self-collection of blood samples.  The Seattle-based company said its interchangeable cartridges ensure that the right blood preparation starts as soon as the sample is taken. And with multiple packaging and logistics options, there's a Tasso configuration that will fit into the workflow.

    Courtesy of Tasso
  • X-COR Therapeutics

    X-COR Therapeutics is a Boston-based medical device company creating the first commercially available CO2 removal device that uses ultra-low-blood flows for a cheaper, safer, and more accessible treatment for acute respiratory failure.


    Courtesy of X-COR Therapeutics

    ZetaGen Therapeutics

    ZetaGen Therapeutics has developed a small molecule-based osteoinductive platform technology to develop bone growth products that activate a novel molecular pathway. Discovered serendipitously, the Berkeley, CA-based firm's products have the potential to transform the treatment of bone-related injuries, procedures and diseases to deliver better outcomes for patients, doctors and payors.

Filed Under
500 characters remaining